DXRX Diaceutics PLC

LSE · GB · Healthcare · Health Information Services · diaceutics.com

193.00GBp-1.03%Mkt Cap: 178.09M $P/E: —Today

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for pr…

Industry Peers

Health Information Services

Screen all

VEEV

Veeva Systems Inc. Class A Common Stock

$44.25BUSDP/E 44.9

TEM

Tempus AI, Inc. - Class A Common Stock

$13.83BUSD

BTSG

BrightSpring Health Services, Inc. - Common Stock

$11.92BUSDP/E 53.8

HNGE

Hinge Health, Inc. Class A Common Stock

$7.88BUSDP/E 11.9

HQY

HealthEquity, Inc. - Common Stock

$7.45BUSDP/E 32.5

DOCS

Doximity, Inc. Class A Common Stock

$4.98BUSDP/E 31.0

WAY

Waystar Holding Corp. - Common Stock

$4.76BUSDP/E 35.4

HTFL

Heartflow, Inc. - Common Stock

$4.29BUSD

PRVA

Privia Health Group, Inc. - Common Stock

$2.59BUSDP/E 92.3

SDGR

Schrodinger, Inc. - Common Stock

$2.27BUSD

OMCL

Omnicell, Inc. - Common Stock

$1.53BUSDP/E 40.0

CERT

Certara, Inc. - Common Stock

$1.43BUSD

OMDA

Omada Health, Inc. - Common Stock

$1.25BUSDP/E 30.4

GDRX

GoodRx Holdings, Inc. - Class A Common Stock

$1.12BUSDP/E 54.7

TDOC

Teladoc Health, Inc. Common Stock

$1.00BUSD

HSTM

HealthStream, Inc. - Common Stock

$942.97MUSDP/E 42.8

SOPH

SOPHiA GENETICS SA - Ordinary Shares

$686.98MUSD

PHR

Phreesia, Inc. Common Stock

$625.05MUSDP/E 55.9

WEAV

Weave Communications, Inc. Common Stock

$592.92MUSD

RAY-B

RaySearch Laboratories AB (publ)

$523.69MUSDP/E 29.5

Key Statistics

Company

Market Cap178.09M USD

Enterprise Value173.07M USD

Revenue (TTM)44.92M USD

Gross Profit34.22M USD

Net Income (TTM)105.43K USD

Revenue/Share0.49 GBp

Last Price193.00 GBp

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees205

CountryGB

SectorHealthcare

IndustryHealth Information Services

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)48.09

PEG—

EV/EBITDA41.27

EV/Revenue3.85

P/S4.01

P/B4.08

EPS (TTM)0.00

EPS (Forward)0.04

52W Range

0.000098% of range197.00

52W High197.00 GBp

52W Low0.0000 GBp

Profitability

Gross Margin81.90%

Oper. Margin-23.01%

EBITDA Margin9.34%

Profit Margin0.25%

ROE0.24%

ROA0.19%

Growth

Revenue Growth19.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF1.28M USD

CapEx (TTM)7.01M USD

FCF Margin-1.09%

FCF Yield-0.27%

Net Debt-6.53M USD

Net Debt/EBITDA-1.56

Balance Sheet

Debt/Equity0.03

Current Ratio2.56

Quick Ratio2.33

Book Value/Sh0.48 GBp

Cash/Share0.10 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 GBp

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.2 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)213.00 GBp

Upside (mean)+10.4%

Target Range185.00 GBp – 235.00 GBp

185.00+10.4% to mean235.00

# Analysts5

Ownership

Shares Out.84.89M

Float48.83M

Insiders27.82%

Institutions64.33%

Technical

SMA 50155.16 (+24.4%)

SMA 200153.59 (+25.7%)

Beta0.88

S&P 52W Chg14.58%

Avg Vol (30d)212.40K

Avg Vol (10d)456.54K

Technical Indicators

RSI (14)81.5

MACD12.4415

MACD Signal10.9802

MACD Hist.+1.4614

BB Upper209.19 GBp

BB Middle173.05 GBp

BB Lower136.91 GBp

BB Width41.77%

ATR (14)6.746 GBp

Vol Ratio (20d)0.35x